Status:
UNKNOWN
Outcomes of Mitral Valve Surgery in Patients Affected by Rheumatic Heart Disease
Lead Sponsor:
Beijing Anzhen Hospital
Conditions:
Outcomes of Mitral Valve Surgery in Patients Affected by Rheumatic Heart Disease
Eligibility:
All Genders
Brief Summary
rheumatic heart disease remains the majority valvular disease in low and middle income countries, which mostly affected mitral valve, surgical treatment is the most effective strategy to improve the o...
Eligibility Criteria
Inclusion
- 1、rheumatic heart disease 2、mitral valve disease 3、combined with other heart valve disease(aortic valve, tricuspid valve, pulmonary valve) 4、patients underwent initial mitral valve surgery or intervention
Exclusion
- 1、congenital heart disease degenerative heart valve disease 2、isolated aortic valve or tricuspid valve, pulmonary valve disease( doesn't affect mitral valve ) 3、patients received more than 1 time mitral valve operation
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT04780607
Start Date
January 1 2011
End Date
April 1 2024
Last Update
March 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Anzhen Hospital
Beijing, Beijing Municipality, China, 100086